CPC Scientific Inc.
David A. Godkin has a diverse and extensive work experience. David A. is currently serving as the VP of Business Operations and Human Resources at CPC Scientific Inc. Prior to this, David held the position of Senior Project Manager at Applied Construction Technology, Inc., where they managed general building construction projects generating $30M in annual revenue. David A. also served as the Division Manager, Northern California at LCS Constructors, Inc., overseeing projects worth approximately $1.5M. David's earlier experience includes working as the Vice President of Finance & Administration / Chief Financial Officer (CFO) at American Peptide Company, where they played a key role in guiding corporate strategy, driving diversification, and ensuring profitability during volatile market conditions.
David A. Godkin has a Bachelor of Arts (B.A.) degree in Japanese Language (International Business) from the University of California, Berkeley. Additionally, they were an exchange student at Yamate Gakuen in Yokohama, Japan, where they studied Japanese Language and Culture.
CPC Scientific Inc.
1 followers
With over 20 years of experience, CPC Scientific is a global CRDMO specializing in peptides and oligonucleotides. Our integrated service model supports partners through critical drug development stages, focusing on late-phase, large-scale, and commercial production. We provide GMP-grade synthetic peptides, oligonucleotides, and peptide-oligonucleotide conjugates, plus a wide range of custom and catalog research products. Our FDA- and ICH-compliant GMP facility ensures regulatory support for IND, NDA, and global filings. We offer process and method development, validation, stability studies, and regulatory documentation to accelerate your program from clinical trials to market. With scalable capacity from milligrams to 100 kilograms, flexible infrastructure, and a robust supply chain, CPC Scientific delivers dependable, high-quality results at every phase, providing the expertise and speed to bring your peptide and oligonucleotide programs to successful commercial production.